TruBridge, Inc. (NASDAQ:TBRG – Get Free Report) major shareholder Pinetree Capital Ltd. bought 74,981 shares of the business’s stock in a transaction on Thursday, February 13th. The stock was bought at an average price of $27.61 per share, for a total transaction of $2,070,225.41. Following the transaction, the insider now directly owns 693,981 shares of the company’s stock, valued at approximately $19,160,815.41. This represents a 12.11 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
Pinetree Capital Ltd. also recently made the following trade(s):
- On Tuesday, February 18th, Pinetree Capital Ltd. purchased 6,795 shares of TruBridge stock. The shares were bought at an average price of $28.16 per share, with a total value of $191,347.20.
TruBridge Stock Up 0.3 %
Shares of NASDAQ:TBRG opened at $28.25 on Wednesday. The firm has a market cap of $421.77 million, a P/E ratio of -6.91, a P/E/G ratio of 4.90 and a beta of 0.69. TruBridge, Inc. has a 12-month low of $7.55 and a 12-month high of $28.70. The business has a fifty day simple moving average of $22.24 and a 200 day simple moving average of $16.56. The company has a quick ratio of 1.78, a current ratio of 1.80 and a debt-to-equity ratio of 1.00.
Wall Street Analysts Forecast Growth
Get Our Latest Analysis on TruBridge
Hedge Funds Weigh In On TruBridge
Hedge funds have recently made changes to their positions in the stock. Covestor Ltd boosted its holdings in TruBridge by 20.5% in the fourth quarter. Covestor Ltd now owns 2,819 shares of the company’s stock valued at $56,000 after acquiring an additional 479 shares during the last quarter. Cubist Systematic Strategies LLC boosted its stake in shares of TruBridge by 2.0% in the 4th quarter. Cubist Systematic Strategies LLC now owns 26,202 shares of the company’s stock valued at $517,000 after purchasing an additional 514 shares during the last quarter. Tower Research Capital LLC TRC increased its position in shares of TruBridge by 47.5% during the fourth quarter. Tower Research Capital LLC TRC now owns 2,170 shares of the company’s stock worth $43,000 after buying an additional 699 shares during the period. Charles Schwab Investment Management Inc. raised its stake in TruBridge by 1.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 73,879 shares of the company’s stock worth $1,457,000 after buying an additional 716 shares during the last quarter. Finally, Trexquant Investment LP lifted its holdings in TruBridge by 14.4% in the fourth quarter. Trexquant Investment LP now owns 16,760 shares of the company’s stock valued at $331,000 after buying an additional 2,112 shares during the period. 88.64% of the stock is currently owned by institutional investors.
TruBridge Company Profile
TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.
Featured Stories
- Five stocks we like better than TruBridge
- What is the Australian Securities Exchange (ASX)
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- What Are Trending Stocks? Trending Stocks Explained
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for TruBridge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TruBridge and related companies with MarketBeat.com's FREE daily email newsletter.